18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas-Reference-Cited by-同舟云学术

18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas

Published:2014-02-12 Issue:3 Volume:44 Page:325-332
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Blanchet Elise M.¹,Gabriel Sophie²,Martucci Victoria¹,Fakhry Nicolas³,Chen Clara C.⁴,Deveze Arnaud⁵,Millo Corina⁶,Barlier Anne⁷,Pertuit Morgane⁷,Loundou Anderson⁸,Pacak Karel¹,Taïeb David²

Affiliation:

1. Program in Reproductive and Adult Endocrinology; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health; Bethesda MD USA

2. Department of Nuclear Medicine; La Timone University Hospital; CERIMED; Aix-Marseille University; Marseille France

3. Department of Otorhinolaryngology-Head and Neck Surgery; La Timone University Hospital; Aix-Marseille University; Marseille France

4. Nuclear Medicine Department; Radiology and Imaging Sciences; Warren Magnuson Clinical Center; National Institutes of Health; Bethesda MD USA

5. Department of Otorhinolaryngology-Head and Neck Surgery; North Hospital; Aix-Marseille University; Marseille France

6. PET Department; Warren Magnuson Clinical Center; National Institutes of Health; Bethesda MD USA

7. Laboratory of Biochemistry and Molecular Biology; Conception Hospital; Aix-Marseille University; Marseille France

8. Department of Public Health; Aix-Marseille University; Marseille France

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/eci.12239/fullpdf

Reference18 articles.

1. Extraadrenal paragangliomas of the body: imaging features;Lee;Am J Roentgenol,2006

2. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out;Neumann;Cancer Res,2009

3. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas;Mannelli;J Clin Endocrinol Metab,2009

4. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas;Burnichon;J Clin Endocrinol Metab,2009

5. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma;Jafri;Clin Endocrinol,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SDH-related head and neck paragangliomas: Unraveling PET radiomics beyond 18F-FDG;Best Practice & Research Clinical Endocrinology & Metabolism;2024-08

2. The Additional Value of Somatostatin Receptor Positron Emission Computed Tomography ([68Ga]Ga-DOTATOC PET/CT) Compared with Magnetic Resonance Imaging of the Head and Neck Region in Paraganglioma Patients: A Pilot Study;Cancers;2024-02-28

3. Current Status of Cancer Genomics and Imaging Phenotypes: What Radiologists Need to Know;Radiology: Imaging Cancer;2023-11-01

4. Synchronous carotid body and anterior mediastinal paraganglioma revealed by 18F-fluorodeoxyglucose and 68Ga-DOTA(0)-Tyr(3)-octreotate positron emission tomography-computed tomography;Quantitative Imaging in Medicine and Surgery;2023-06

5. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants;The Lancet Diabetes & Endocrinology;2023-05